Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Selumetinib sulfate by AstraZeneca for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma): Likelihood of Approval
Selumetinib sulfate is under clinical development by AstraZeneca and currently in Phase II for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). According...
Selumetinib sulfate by AstraZeneca for Glioma: Likelihood of Approval
Selumetinib sulfate is under clinical development by AstraZeneca and currently in Phase II for Glioma. According to GlobalData, Phase II...
Selumetinib sulfate by AstraZeneca for Low-Grade Glioma: Likelihood of Approval
Selumetinib sulfate is under clinical development by AstraZeneca and currently in Phase II for Low-Grade Glioma. According to GlobalData, Phase...